HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoki Tanaka Selected Research

R-102444

10/2005Effects of R-102444 and its active metabolite R-96544, selective 5-HT2A receptor antagonists, on experimental acute and chronic pancreatitis: Additional evidence for possible involvement of 5-HT2A receptors in the development of experimental pancreatitis.
2/2004Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoki Tanaka Research Topics

Disease

24Neoplasms (Cancer)
02/2022 - 01/2009
23Non-alcoholic Fatty Liver Disease
04/2022 - 06/2002
22Fibrosis (Cirrhosis)
04/2022 - 10/2004
19Inflammation (Inflammations)
01/2022 - 10/2004
11Body Weight (Weight, Body)
06/2021 - 04/2008
11Fatty Liver
06/2021 - 04/2008
9Carcinogenesis
11/2020 - 06/2006
9Alcoholic Fatty Liver
02/2020 - 11/2008
7Hemorrhage
01/2022 - 01/2011
7Liver Diseases (Liver Disease)
10/2020 - 11/2014
7Hepatitis
05/2017 - 11/2004
6Liver Cirrhosis (Hepatic Cirrhosis)
04/2022 - 06/2009
6Obesity
01/2022 - 11/2006
6Polyps
12/2021 - 01/2011
6Rectal Neoplasms (Rectal Cancer)
04/2019 - 11/2014
6Stomach Neoplasms (Stomach Cancer)
01/2018 - 05/2010
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 11/2008
5Insulin Resistance
01/2022 - 09/2008
5Neoplasm Metastasis (Metastasis)
12/2019 - 05/2010
5Hepatocellular Carcinoma (Hepatoma)
01/2019 - 01/2003
5Chronic Disease (Chronic Diseases)
11/2018 - 01/2017
5Anemia
11/2018 - 01/2017
5Chronic Hepatitis C
05/2017 - 03/2004
5Necrosis
10/2016 - 11/2010
4Stroke (Strokes)
10/2022 - 06/2012
4Type 2 Diabetes Mellitus (MODY)
01/2021 - 05/2016
4Infections
10/2020 - 02/2006
4Alzheimer Disease (Alzheimer's Disease)
01/2020 - 05/2007
3Lymphatic Metastasis
12/2021 - 11/2014
3Liver Neoplasms (Liver Cancer)
11/2020 - 02/2014
3Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 01/2019
3Diabetes Mellitus
04/2018 - 05/2012
3Colonic Neoplasms (Colon Cancer)
11/2017 - 12/2014
3Ascites
02/2017 - 01/2007
3Cholestasis
12/2013 - 04/2011
3Respiratory Insufficiency (Respiratory Failure)
02/2012 - 01/2008
2Dyslipidemias (Dyslipidemia)
06/2022 - 01/2015
2Weight Gain
01/2022 - 05/2016
2Thrombosis (Thrombus)
10/2020 - 01/2019
2Hyperlipidemias (Hyperlipidemia)
09/2020 - 12/2002
2Aspiration Pneumonia
05/2019 - 05/2013
2Intrahepatic Cholestasis
05/2019 - 12/2012

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
12/2017 - 12/2002
9Fatty Acids (Saturated Fatty Acids)IBA
09/2021 - 07/2002
9Ethanol (Ethyl Alcohol)IBA
09/2020 - 10/2004
8Biomarkers (Surrogate Marker)IBA
04/2022 - 07/2010
8CholesterolIBA
01/2022 - 06/2011
8Bile Acids and Salts (Bile Acids)IBA
12/2018 - 07/2012
7Messenger RNA (mRNA)IBA
10/2021 - 04/2008
7PPAR alphaIBA
11/2010 - 07/2002
6Sulfoglycosphingolipids (Sulfatides)IBA
01/2022 - 01/2012
6LipidsIBA
05/2019 - 10/2004
5HepcidinsIBA
11/2018 - 01/2017
5Choline (Choline Chloride)IBA
12/2017 - 10/2005
5Methionine (L-Methionine)FDA Link
12/2017 - 07/2012
5Serum AlbuminIBA
02/2017 - 01/2007
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2016 - 06/2002
4Pharmaceutical PreparationsIBA
06/2021 - 01/2016
4Insulin (Novolin)FDA Link
01/2021 - 04/2008
4Glucose (Dextrose)FDA LinkGeneric
12/2020 - 05/2016
4Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2020 - 04/2008
3(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
06/2022 - 06/2021
3Alanine Transaminase (SGPT)IBA
10/2021 - 01/2009
3Trans Fatty AcidsIBA
09/2021 - 01/2017
3Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2021 - 01/2018
3NF-kappa B (NF-kB)IBA
11/2020 - 01/2017
3Anti-Bacterial Agents (Antibiotics)IBA
10/2020 - 02/2006
3isothiocyanic acidIBA
05/2019 - 01/2017
3Triglycerides (Triacylglycerol)IBA
01/2019 - 10/2010
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2017 - 11/2012
3InterferonsIBA
05/2017 - 01/2003
3AzoxymethaneIBA
09/2015 - 05/2014
3EnzymesIBA
12/2013 - 04/2008
3Phospholipids (Phosphatides)FDA LinkGeneric
12/2012 - 04/2011
3Transaminases (Aminotransferases)IBA
01/2009 - 09/2008
2ElementsIBA
10/2022 - 09/2014
2Collagen Type IV (Type IV Collagen)IBA
04/2022 - 01/2021
2Hyaluronic Acid (Hyaluronan)IBA
04/2022 - 01/2021
2C-Reactive ProteinIBA
01/2022 - 10/2020
2Antiviral Agents (Antivirals)IBA
01/2022 - 05/2017
2Hemostatics (Antihemorrhagics)IBA
01/2022 - 01/2021
2Fibric Acids (Fibrates)IBA
06/2021 - 09/2014
2nasIBA
01/2021 - 07/2010
2Keratin-18 (Keratin 18)IBA
01/2021 - 07/2010
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021 - 10/2020
2AnticoagulantsIBA
10/2020 - 03/2014
2Prednisolone (Predate)FDA LinkGeneric
06/2020 - 08/2018
2CateninsIBA
01/2020 - 05/2014
2Imatinib Mesylate (Gleevec)FDA Link
12/2019 - 11/2016

Therapy/Procedure

20Therapeutics
10/2022 - 12/2002
8Gastrectomy
01/2021 - 04/2012
7Drug Therapy (Chemotherapy)
04/2019 - 05/2010
5Bariatric Surgery
01/2021 - 05/2012
4Gastrostomy
05/2019 - 02/2006
3Neoadjuvant Therapy
12/2018 - 11/2014
3Lymph Node Excision (Lymph Node Dissection)
12/2018 - 11/2013
3Intraperitoneal Injections
01/2017 - 10/2005
3Laparotomy
11/2014 - 01/2010
3Decompression
09/2014 - 09/2008
2Diet Therapy (Therapy, Diet)
09/2020 - 01/2010